Login Register Cart 0
Review Article

布鲁氏菌病的研究进展

卷 26, 期 30, 2019

页: [5598 - 5608] 页: 11

弟呕挨: 10.2174/0929867325666180510125009

价格: $65

摘要

布氏杆菌病是由细胞内布氏杆菌引起的衰弱性高热疾病。 该病广泛分布在人和动物中，特别是在发展中国家。 如今，布鲁氏菌属中包括十种。 其中有4种对人类具有致病性，这使布鲁氏菌病成为人畜共患病，每年报告超过500,000例新病例。 对于人类布鲁氏菌病，最具致病性的物种是肉芽孢杆菌，其次是猪芽孢杆菌，而流产芽孢杆菌是布鲁氏菌病最轻的类型。 布鲁氏菌的感染机制很复杂，并且主要取决于其毒力因子。 该病的治疗方法包括接种疫苗和抗生素。 但是，目前可用的疫苗存在一些缺陷，例如较低的保护水平和安全性。 因此，仍在等待安全有效的布鲁氏菌病疫苗。 如果找到一种快速，准确的检测方法，则双重抗菌疗法可有效治疗布鲁氏菌病。

关键词: 布鲁氏菌，布鲁氏菌病，病原体，治疗，高热病，属，人畜共患病。

« Previous Next »
[1]
Pappas, G.; Akritidis, N.; Bosilkovski, M.; Tsianos, E. Brucellosis. N. Engl. J. Med., 2005, 352(22), 2325-2336.
[http://dx.doi.org/10.1056/NEJMra050570] [PMID: 15930423]
[2]
Seleem, M.N.; Boyle, S.M.; Sriranganathan, N. Brucellosis: a re-emerging zoonosis. Vet. Microbiol., 2010, 140(3-4), 392-398.
[http://dx.doi.org/10.1016/j.vetmic.2009.06.021] [PMID: 19604656]
[3]
Celli, J.; de Chastellier, C.; Franchini, D.M.; Pizarro-Cerda, J.; Moreno, E.; Gorvel, J.P. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J. Exp. Med., 2003, 198(4), 545-556.
[http://dx.doi.org/10.1084/jem.20030088] [PMID: 12925673]
[4]
Seleem, M.N.; Boyle, S.M.; Sriranganathan, N. Brucella: a pathogen without classic virulence genes. Vet. Microbiol., 2008, 129(1-2), 1-14.
[http://dx.doi.org/10.1016/j.vetmic.2007.11.023] [PMID: 18226477]
[5]
Godfroid, J.; Nielsen, K.; Saegerman, C. Diagnosis of brucellosis in livestock and wildlife. Croat. Med. J., 2010, 51(4), 296-305.
[http://dx.doi.org/10.3325/cmj.2010.51.296] [PMID: 20718082]
[6]
Moreno, E. Retrospective and prospective perspectives on zoonotic brucellosis. Front. Microbiol., 2014, 5, 213.
[http://dx.doi.org/10.3389/fmicb.2014.00213] [PMID: 24860561]
[7]
Ducrotoy, M.J.; Conde-Álvarez, R.; Blasco, J.M.; Moriyón, I. A review of the basis of the immunological diagnosis of ruminant brucellosis. Vet. Immunol. Immunopathol., 2016, 171, 81-102.
[http://dx.doi.org/10.1016/j.vetimm.2016.02.002] [PMID: 26964721]
[8]
Ley, J.D.; Mannheim, W.; Segers, P.; Lievens, A.; Denijn, M.; Vanhoucke, M.; Gillis, M. Ribosomal ribonucleic acid cistron similarities and taxonomic neighborhood of Brucella and CDC group Vd. Int. J. Syst. Bacteriol., 1987, 37(1), 35-42.
[http://dx.doi.org/10.1099/00207713-37-1-35]
[9]
Forestier, C.; Moreno, E.; Pizarro-Cerda, J.; Gorvel, J.P. Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study. J Immunol. (Baltimore, Md.:1950), , 1999, 162(11), 6784-6791.
[PMID: 10352299]
[10]
Chandran, V. Type IV secretion machinery: molecular architecture and function. Biochem. Soc. Trans., 2013, 41(1), 17-28.
[http://dx.doi.org/10.1042/BST20120332] [PMID: 23356253]
[11]
Arellano-Reynoso, B.; Lapaque, N.; Salcedo, S.; Briones, G.; Ciocchini, A.E.; Ugalde, R.; Moreno, E.; Moriyón, I.; Gorvel, J.P. Cyclic beta-1,2-glucan is a Brucella virulence factor required for intracellular survival. Nat. Immunol., 2005, 6(6), 618-625.
[http://dx.doi.org/10.1038/ni1202] [PMID: 15880113]
[12]
Beck, B.L.; Tabatabai, L.B.; Mayfield, J.E. A protein isolated from Brucella abortus is a Cu-Zn superoxide dismutase. Biochemistry, 1990, 29(2), 372-376.
[http://dx.doi.org/10.1021/bi00454a010] [PMID: 2105741]
[13]
Jiang, X.; Baldwin, C.L. Effects of cytokines on intracellular growth of Brucella abortus. Infect. Immun., 1993, 61(1), 124-134.
[PMID: 8418034]
[14]
Hornback, M.L.; Roop, R.M., II The Brucella abortus xthA-1 gene product participates in base excision repair and resistance to oxidative killing but is not required for wild-type virulence in the mouse model. J. Bacteriol., 2006, 188(4), 1295-1300.
[http://dx.doi.org/10.1128/JB.188.4.1295-1300.2006] [PMID: 16452411]
[15]
Bandara, A.B.; Contreras, A.; Contreras-Rodriguez, A.; Martins, A.M.; Dobrean, V.; Poff-Reichow, S.; Rajasekaran, P.; Sriranganathan, N.; Schurig, G.G.; Boyle, S.M. Brucella suis urease encoded by ure1 but not ure2 is necessary for intestinal infection of BALB/c mice. BMC Microbiol., 2007, 7, 57.
[http://dx.doi.org/10.1186/1471-2180-7-57] [PMID: 17578575]
[16]
Endley, S.; McMurray, D.; Ficht, T.A. Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection. J. Bacteriol., 2001, 183(8), 2454-2462.
[http://dx.doi.org/10.1128/JB.183.8.2454-2462.2001] [PMID: 11274104]
[17]
Lavigne, J.P.; Patey, G.; Sangari, F.J.; Bourg, G.; Ramuz, M.; O’Callaghan, D.; Michaux-Charachon, S. Identification of a new virulence factor, BvfA, in Brucella suis. Infect. Immun., 2005, 73(9), 5524-5529.
[http://dx.doi.org/10.1128/IAI.73.9.5524-5529.2005] [PMID: 16113268]
[18]
Rossetti, C.A.; Drake, K.L.; Siddavatam, P.; Lawhon, S.D.; Nunes, J.E.; Gull, T.; Khare, S.; Everts, R.E.; Lewin, H.A.; Adams, L.G. Systems biology analysis of Brucella infected Peyer’s patch reveals rapid invasion with modest transient perturbations of the host transcriptome. PLoS One, 2013, 8(12)e81719
[http://dx.doi.org/10.1371/journal.pone.0081719] [PMID: 24349118]
[19]
Smith, J.A.; Khan, M.; Magnani, D.D.; Harms, J.S.; Durward, M.; Radhakrishnan, G.K.; Liu, Y.P.; Splitter, G.A. Brucella induces an unfolded protein response via TcpB that supports intracellular replication in macrophages. PLoS Pathog., 2013, 9(12)e1003785
[http://dx.doi.org/10.1371/journal.ppat.1003785] [PMID: 24339776]
[20]
de Figueiredo, P.; Ficht, T.A.; Rice-Ficht, A.; Rossetti, C.A.; Adams, L.G. Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions. Am. J. Pathol., 2015, 185(6), 1505-1517.
[http://dx.doi.org/10.1016/j.ajpath.2015.03.003] [PMID: 25892682]
[21]
Adams, L.G. The pathology of brucellosis reflects the outcome of the battle between the host genome and the Brucella genome. Vet. Microbiol., 2002, 90(1-4), 553-561.
[http://dx.doi.org/10.1016/S0378-1135(02)00235-3] [PMID: 12414171]
[22]
Dornand, J.; Gross, A.; Lafont, V.; Liautard, J.; Oliaro, J.; Liautard, J.P. The innate immune response against Brucella in humans. Vet. Microbiol., 2002, 90(1-4), 383-394.
[http://dx.doi.org/10.1016/S0378-1135(02)00223-7] [PMID: 12414158]
[23]
Arenas, G.N.; Staskevich, A.S.; Aballay, A.; Mayorga, L.S. Intracellular trafficking of Brucella abortus in J774 macrophages. Infect. Immun., 2000, 68(7), 4255-4263.
[http://dx.doi.org/10.1128/IAI.68.7.4255-4263.2000] [PMID: 10858243]
[24]
Pizarro-Cerdá, J.; Moreno, E.; Sanguedolce, V.; Mege, J.L.; Gorvel, J.P. Virulent Brucella abortus prevents lysosome fusion and is distributed within autophagosome-like compartments. Infect. Immun., 1998, 66(5), 2387-2392.
[PMID: 9573138]
[25]
Gorvel, J.P.; Moreno, E. Brucella intracellular life: from invasion to intracellular replication. Vet. Microbiol., 2002, 90(1-4), 281-297.
[http://dx.doi.org/10.1016/S0378-1135(02)00214-6] [PMID: 12414149]
[26]
Sola-Landa, A.; Pizarro-Cerdá, J.; Grilló, M.J.; Moreno, E.; Moriyón, I.; Blasco, J.M.; Gorvel, J.P.; López-Goñi, I. A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol. Microbiol., 1998, 29(1), 125-138.
[http://dx.doi.org/10.1046/j.1365-2958.1998.00913.x] [PMID: 9701808]
[27]
Galińska, E.M.; Zagórski, J. Brucellosis in humans--etiology, diagnostics, clinical forms. Ann. Agric. Environ. Med., 2013, 20(2), 233-238.
[PMID: 23772567]
[28]
Corbel, M.J. Brucellosis: an overview. Emerg. Infect. Dis., 1997, 3(2), 213-221.
[http://dx.doi.org/10.3201/eid0302.970219] [PMID: 9204307]
[29]
Spink, W.W.; Hoffbauer, F.W. Histopathology of the liver in human brucellosis. J. Lab. Clin. Med., 1949, 34(1), 40-58.
[PMID: 18106408]
[30]
Williams, R.K.; Crossley, K. Acute and chronic hepatic involvement of brucellosis. Gastroenterology, 1982, 83(2), 455-458.
[PMID: 7084621]
[31]
Chacón-Díaz, C.; Altamirano-Silva, P.; González-Espinoza, G.; Medina, M.C.; Alfaro-Alarcón, A.; Bouza-Mora, L.; Jiménez-Rojas, C.; Wong, M.; Barquero-Calvo, E.; Rojas, N.; Guzmán-Verri, C.; Moreno, E.; Chaves-Olarte, E. Brucella canis is an intracellular pathogen that induces a lower proinflammatory response than smooth zoonotic counterparts. Infect. Immun., 2015, 83(12), 4861-4870.
[http://dx.doi.org/10.1128/IAI.00995-15] [PMID: 26438796]
[32]
Olsen, S.C.; Palmer, M.V. Advancement of knowledge of Brucella over the past 50 years. Vet. Pathol., 2014, 51(6), 1076-1089.
[http://dx.doi.org/10.1177/0300985814540545] [PMID: 24981716]
[33]
Covert, J.; Mathison, A.J.; Eskra, L.; Banai, M.; Splitter, G. Brucella melitensis, B. neotomae and B. ovis elicit common and distinctive macrophage defense transcriptional responses. Exp. Biol. Med. (Maywood), 2009, 234(12), 1450-1467.
[http://dx.doi.org/10.3181/0904-RM-124] [PMID: 19934366]
[34]
Bricker, B.J.; Ewalt, D.R.; MacMillan, A.P.; Foster, G.; Brew, S. Molecular characterization of Brucella strains isolated from marine mammals. J. Clin. Microbiol., 2000, 38(3), 1258-1262.
[PMID: 10699036]
[35]
Rónai, Z.; Kreizinger, Z.; Dán, Á.; Drees, K.; Foster, J.T.; Bányai, K.; Marton, S.; Szeredi, L.; Jánosi, S.; Gyuranecz, M. First isolation and characterization of Brucella microti from wild boar. BMC Vet. Res., 2015, 11, 147.
[http://dx.doi.org/10.1186/s12917-015-0456-z] [PMID: 26163135]
[36]
Scholz, H.C.; Nöckler, K.; Göllner, C.; Bahn, P.; Vergnaud, G.; Tomaso, H.; Al Dahouk, S.; Kämpfer, P.; Cloeckaert, A.; Maquart, M.; Zygmunt, M.S.; Whatmore, A.M.; Pfeffer, M.; Huber, B.; Busse, H.J.; De, B.K. Brucella inopinata sp. nov., isolated from a breast implant infection. Int. J. Syst. Evol. Microbiol., 2010, 60(Pt 4), 801-808.
[http://dx.doi.org/10.1099/ijs.0.011148-0] [PMID: 19661515]
[37]
Whatmore, A.M.; Davison, N.; Cloeckaert, A.; Al Dahouk, S.; Zygmunt, M.S.; Brew, S.D.; Perrett, L.L.; Koylass, M.S.; Vergnaud, G.; Quance, C.; Scholz, H.C.; Dick, E.J. Jr.; Hubbard, G.; Schlabritz-Loutsevitch, N.E. Brucella papionis sp. nov., isolated from baboons (Papio spp.). Int. J. Syst. Evol. Microbiol., 2014, 64(Pt 12), 4120-4128.
[http://dx.doi.org/10.1099/ijs.0.065482-0] [PMID: 25242540]
[38]
Schlabritz-Loutsevitch, N.E.; Whatmore, A.M.; Quance, C.R.; Koylass, M.S.; Cummins, L.B.; Dick, E.J., Jr; Snider, C.L.; Cappelli, D.; Ebersole, J.L.; Nathanielsz, P.W.; Hubbard, G.B. A novel Brucella isolate in association with two cases of stillbirth in non-human primates - first report. J. Med. Primatol., 2009, 38(1), 70-73.
[http://dx.doi.org/10.1111/j.1600-0684.2008.00314.x] [PMID: 19187435]
[39]
Banai, M.; Itin, R.; Bardenstein, S. Perspectives and outcomes of the activity of a reference laboratory for brucellosis. Front. Vet. Sci., 2018, 4, 234.
[http://dx.doi.org/10.3389/fvets.2017.00234] [PMID: 29354639]
[40]
Scholz, H.C.; Revilla-Fernández, S.; Al Dahouk, S.; Hammerl, J.A.; Zygmunt, M.S.; Cloeckaert, A.; Koylass, M.; Whatmore, A.M.; Blom, J.; Vergnaud, G.; Witte, A.; Aistleitner, K.; Hofer, E. Brucella vulpis sp. nov., isolated from mandibular lymph nodes of red foxes (Vulpes vulpes). Int. J. Syst. Evol. Microbiol., 2016, 66(5), 2090-2098.
[http://dx.doi.org/10.1099/ijsem.0.000998] [PMID: 26928956]
[41]
Eisenberg, T.; Hamann, H.P.; Kaim, U.; Schlez, K.; Seeger, H.; Schauerte, N.; Melzer, F.; Tomaso, H.; Scholz, H.C.; Koylass, M.S.; Whatmore, A.M.; Zschöck, M. Isolation of potentially novel Brucella spp. from frogs. Appl. Environ. Microbiol., 2012, 78(10), 3753-3755.
[http://dx.doi.org/10.1128/AEM.07509-11] [PMID: 22407680]
[42]
Traxler, R.M.; Lehman, M.W.; Bosserman, E.A.; Guerra, M.A.; Smith, T.L. A literature review of laboratory-acquired brucellosis. J. Clin. Microbiol., 2013, 51(9), 3055-3062.
[http://dx.doi.org/10.1128/JCM.00135-13] [PMID: 23824774]
[43]
Roushan, M.R.; Amiri, M.J. Update on childhood brucellosis. Recent Pat Antiinfect Drug Discov, 2013, 8(1), 42-46.
[http://dx.doi.org/10.2174/1574891X11308010008] [PMID: 22812616]
[44]
Tuon, F.F.; Gondolfo, R.B.; Cerchiari, N. Human-to-human transmission of Brucella - a systematic review. Trop. Med. Int. Health, 2017, 22(5), 539-546.
[PMID: 28196298] [http://dx.doi.org/10.1111/tmi.12856]
[45]
Young, E.J. An overview of human brucellosis. Clin. Infect. Dis., 1995, 21(2), 283-289.
[http://dx.doi.org/10.1093/clinids/21.2.283] [PMID: 8562733]
[46]
Godfroid, J.; Al Dahouk, S.; Pappas, G.; Roth, F.; Matope, G.; Muma, J.; Marcotty, T.; Pfeiffer, D.; Skjerve, E.A. “One Health” surveillance and control of brucellosis in developing countries: moving away from improvisation. Comp. Immunol. Microbiol. Infect. Dis., 2013, 36(3), 241-248.
[http://dx.doi.org/10.1016/j.cimid.2012.09.001] [PMID: 23044181]
[47]
Franc, K.A.; Krecek, R.C.; Häsler, B.N.; Arenas-Gamboa, A.M. Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action. BMC Public Health, 2018, 18(1), 125.
[http://dx.doi.org/10.1186/s12889-017-5016-y] [PMID: 29325516]
[48]
Doganay, M.; Aygen, B. Human brucellosis: an overview. Int. J. Infect. Dis., 2003, 7(3), 173-182.
[http://dx.doi.org/10.1016/S1201-9712(03)90049-X]
[49]
Ulu-Kilic, A.; Metan, G.; Alp, E. Clinical presentations and diagnosis of brucellosis. Recent Pat. Antiinfect. Drug Discov., 2013, 8(1), 34-41.
[http://dx.doi.org/10.2174/1574891X11308010007] [PMID: 22873352]
[50]
Andriopoulos, P.; Tsironi, M.; Deftereos, S.; Aessopos, A.; Assimakopoulos, G. Acute brucellosis: presentation, diagnosis, and treatment of 144 cases. Int. J. Infect. Dis., 2007, 11(1), 52-57.
[http://dx.doi.org/10.1016/j.ijid.2005.10.011] [PMID: 16651018]
[51]
Kortepeter, M.G.; Parker, G.W. Potential biological weapons threats. Emerg. Infect. Dis., 1999, 5(4), 523-527.
[http://dx.doi.org/10.3201/eid0504.990411] [PMID: 10458957]
[52]
Kaufmann, A.F.; Meltzer, M.I.; Schmid, G.P. The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg. Infect. Dis., 1997, 3(2), 83-94.
[http://dx.doi.org/10.3201/eid0302.970201] [PMID: 9204289]
[53]
Chain, P.S.; Comerci, D.J.; Tolmasky, M.E.; Larimer, F.W.; Malfatti, S.A.; Vergez, L.M.; Aguero, F.; Land, M.L.; Ugalde, R.A.; Garcia, E. Whole-genome analyses of speciation events in pathogenic Brucellae. Infect. Immun., 2005, 73(12), 8353-8361.
[http://dx.doi.org/10.1128/IAI.73.12.8353-8361.2005] [PMID: 16299333]
[54]
Mousa, A.R.; Muhtaseb, S.A.; Almudallal, D.S.; Khodeir, S.M.; Marafie, A.A. Osteoarticular complications of brucellosis: a study of 169 cases. Rev. Infect. Dis., 1987, 9(3), 531-543.
[http://dx.doi.org/10.1093/clinids/9.3.531] [PMID: 3496650]
[55]
Petrella, R.; Young, E.J. Acute Brucella ileitis. Am. J. Gastroenterol., 1988, 83(1), 80-82.
[PMID: 3337066]
[56]
Stermer, E.; Levy, N.; Potasman, I.; Jaffe, M.; Boss, J. Brucellosis as a cause of severe colitis. Am. J. Gastroenterol., 1991, 86(7), 917-919.
[PMID: 2058640]
[57]
Halim, M.A.; Ayub, A.; Abdulkareem, A.; Ellis, M.E.; al-Gazlan, S. Brucella peritonitis. J. Infect., 1993, 27(2), 169-172.
[http://dx.doi.org/10.1016/0163-4453(93)94755-Z] [PMID: 8228298]
[58]
Wang, M.; Zhu, Q.; Yang, Q.; Li, W.; Wang, X.; Liu, W.; Zhou, B.; Li, Z.; Yang, H. Intestinal brucellosis associated with celiac artery and superior mesenteric artery stenosis and with ileum mucosa and submucosa thickening: A case report. Medicine (Baltimore), 2017, 96(2)e5893
[http://dx.doi.org/10.1097/MD.0000000000005893] [PMID: 28079834]
[59]
Khan, M.S.; Humayoon, M.S.; Al Manee, M.S. Epididymo-orchitis and Brucellosis. Br. J. Urol., 1989, 63(1), 87-89.
[http://dx.doi.org/10.1111/j.1464-410X.1989.tb05131.x] [PMID: 2920268]
[60]
Hasanjani Roushan, M.R.; Ebrahimpour, S.; Moulana, Z. Different clinical presentations of brucellosis. Jundishapur J. Microbiol., 2016, 9(4)e33765
[http://dx.doi.org/10.5812/jjm.33765] [PMID: 27284398]
[61]
Lulu, A.R.; Araj, G.F.; Khateeb, M.I.; Mustafa, M.Y.; Yusuf, A.R.; Fenech, F.F. Human brucellosis in Kuwait: a prospective study of 400 cases. Q. J. Med., 1988, 66(249), 39-54.
[PMID: 3051080]
[62]
Al Dahouk, S.; Nöckler, K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev. Anti Infect. Ther., 2011, 9(7), 833-845.
[http://dx.doi.org/10.1586/eri.11.55] [PMID: 21810055]
[63]
Edelsten, R.M. Techniques for the brucellosis laboratory. Vet. Res. Commun., 1989, 13(6), 420-420.
[http://dx.doi.org/10.1007/BF00402562]
[64]
Le Flèche, P.; Jacques, I.; Grayon, M.; Al Dahouk, S.; Bouchon, P.; Denoeud, F.; Nöckler, K.; Neubauer, H.; Guilloteau, L.A.; Vergnaud, G. Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay. BMC Microbiol., 2006, 6, 9.
[http://dx.doi.org/10.1186/1471-2180-6-9] [PMID: 16469109]
[65]
Maquart, M.; Le Flèche, P.; Foster, G.; Tryland, M.; Ramisse, F.; Djønne, B.; Al Dahouk, S.; Jacques, I.; Neubauer, H.; Walravens, K.; Godfroid, J.; Cloeckaert, A.; Vergnaud, G. MLVA-16 typing of 295 marine mammal Brucella isolates from different animal and geographic origins identifies 7 major groups within Brucella ceti and Brucella pinnipedialis. BMC Microbiol., 2009, 9, 145.
[http://dx.doi.org/10.1186/1471-2180-9-145] [PMID: 19619320]
[66]
Whatmore, A.M. Current understanding of the genetic diversity of Brucella, an expanding genus of zoonotic pathogens. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2009, 9(6), 1168-1184.
[http://dx.doi.org/10.1016/j.meegid.2009.07.001]
[67]
Bricker, B.J.; Halling, S.M. Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J. Clin. Microbiol., 1994, 32(11), 2660-2666.
[PMID: 7852552]
[68]
Bricker, B.J. PCR as a diagnostic tool for brucellosis. Vet. Microbiol., 2002, 90(1-4), 435-446.
[http://dx.doi.org/10.1016/S0378-1135(02)00228-6] [PMID: 12414163]
[69]
Bricker, B.J.; Ewalt, D.R.; Olsen, S.C.; Jensen, A.E. Evaluation of the Brucella abortus species-specific polymerase chain reaction assay, an improved version of the Brucella AMOS polymerase chain reaction assay for cattle. J. Vet. Diagn. Invest., 2003, 15(4), 374-378.
[PMID: 12918821] [http://dx.doi.org/10.1177/104063870301500413]
[70]
García-Yoldi, D.; Marín, C.M.; de Miguel, M.J.; Muñoz, P.M.; Vizmanos, J.L.; López-Goñi, I. Multiplex PCR assay for the identification and differentiation of all Brucella species and the vaccine strains Brucella abortus S19 and RB51 and Brucella melitensis Rev1. Clin. Chem., 2006, 52(4), 779-781.
[http://dx.doi.org/10.1373/clinchem.2005.062596] [PMID: 16595839]
[71]
Rose, J.E.; Roepke, M.H. An acidified antigen for detection of nonspecific reactions in the plate-agglutination test for bovine brucellosis. Am. J. Vet. Res., 1957, 18(68), 550-555.
[PMID: 13444570]
[72]
Corrente, M.; Desario, C.; Parisi, A.; Grandolfo, E.; Scaltrito, D.; Vesco, G.; Colao, V.; Buonavoglia, D. Serological diagnosis of bovine brucellosis using B. melitensis strain B115. J. Microbiol. Methods, 2015, 119, 106-109.
[http://dx.doi.org/10.1016/j.mimet.2015.10.012] [PMID: 26476137]
[73]
Araj, G.F.; Lulu, A.R.; Mustafa, M.Y.; Khateeb, M.I. Evaluation of ELISA in the diagnosis of acute and chronic brucellosis in human beings. J. Hyg. (Lond.), 1986, 97(3), 457-469.
[http://dx.doi.org/10.1017/S0022172400063634] [PMID: 3794323]
[74]
Ramírez-Pfeiffer, C.; Nielsen, K.; Smith, P.; Marín-Ricalde, F.; Rodríguez-Padilla, C.; Gomez-Flores, R. Application of the fluorescence polarization assay for detection of caprine antibodies to Brucella melitensis in areas of high prevalence and widespread vaccination. Clin. Vaccine Immunol., 2007, 14(3), 299-303.
[http://dx.doi.org/10.1128/CVI.00350-06] [PMID: 17267588]
[75]
Zuckerman, A.J. Manual of diagnostic tests and vaccines for terrestrial animals fifth edition, world health organisation for animal health. J. Virol. Meth.,; , 2004, 123, p. (2)227.
[76]
Glynn, M.K.; Lynn, T.V. Brucellosis. J. Am. Vet. Med. Assoc., 2008, 233(6), 900-908.
[http://dx.doi.org/10.2460/javma.233.6.900] [PMID: 18795849]
[77]
Avila-Calderón, E.D.; Lopez-Merino, A.; Sriranganathan, N.; Boyle, S.M.; Contreras-Rodríguez, A. A history of the development of Brucella vaccines. BioMed Res. Int., 2013.2013743509
[http://dx.doi.org/10.1155/2013/743509] [PMID: 23862154]
[78]
Araj, G.F. Update on laboratory diagnosis of human brucellosis. Int. J. Antimicrob. Agents, 2010, 36(Suppl. 1), S12-S17.
[http://dx.doi.org/10.1016/j.ijantimicag.2010.06.014] [PMID: 20692128]
[79]
Al Dahouk, S.; Neubauer, H.; Hensel, A.; Schöneberg, I.; Nöckler, K.; Alpers, K.; Merzenich, H.; Stark, K.; Jansen, A. Changing epidemiology of human brucellosis, Germany, 1962-2005. Emerg. Infect. Dis., 2007, 13(12), 1895-1900.
[http://dx.doi.org/10.3201/eid1312.070527] [PMID: 18258041]
[80]
Gwida, M.; Al Dahouk, S.; Melzer, F.; Rösler, U.; Neubauer, H.; Tomaso, H. Brucellosis - regionally emerging zoonotic disease? Croat. Med. J., 2010, 51(4), 289-295.
[http://dx.doi.org/10.3325/cmj.2010.51.289] [PMID: 20718081]
[81]
Al-Tawfiq, J.A.; Memish, Z.A. Antibiotic susceptibility and treatment of brucellosis. Recent Pat. Antiinfect. Drug Discov., 2013, 8(1), 51-54.
[http://dx.doi.org/10.2174/1574891X11308010010] [PMID: 22812615]
[82]
Sayan, M.; Kilic, S.; Uyanik, M.H. Epidemiological survey of rifampicin resistance in clinic isolates of Brucella melitensis obtained from all regions of Turkey. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, , 2012, 18(1), 41-46.
[http://dx.doi.org/10.1007/s10156-011-0281-7]
[83]
Lubani, M.M.; Dudin, K.I.; Sharda, D.C.; Ndhar, D.S.; Araj, G.F.; Hafez, H.A.; al-Saleh, Q.A.; Helin, I.; Salhi, M.M. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr. Infect. Dis. J., 1989, 8(2), 75-78.
[PMID: 2649867]
[84]
Ariza, J.; Bosilkovski, M.; Cascio, A.; Colmenero, J.D.; Corbel, M.J.; Falagas, M.E.; Memish, Z.A.; Roushan, M.R.; Rubinstein, E.; Sipsas, N.V.; Solera, J.; Young, E.J.; Pappas, G. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med., 2007, 4(12)e317
[http://dx.doi.org/10.1371/journal.pmed.0040317] [PMID: 18162038]
[85]
Skalsky, K.; Yahav, D.; Bishara, J.; Pitlik, S.; Leibovici, L.; Paul, M. Treatment of human brucellosis: systematic review and meta-analysis of randomised controlled trials. BMJ, 2008, 336(7646), 701-704.
[http://dx.doi.org/10.1136/bmj.39497.500903.25] [PMID: 18321957]
[86]
Schurig, G.G.; Sriranganathan, N.; Corbel, M.J. Brucellosis vaccines: past, present and future. Vet. Microbiol., 2002, 90(1-4), 479-496.
[http://dx.doi.org/10.1016/S0378-1135(02)00255-9] [PMID: 12414166]
[87]
Sterne, M.; Trim, G.; Broughton, E.S. Immunisation of laboratory animals and cattle with non-agglutinogenic extracts of Brucella abortus strain 45-20. J. Med. Microbiol., 1971, 4(2), 185-194.
[http://dx.doi.org/10.1099/00222615-4-2-185] [PMID: 4998854]
[88]
Moriyón, I.; Grilló, M.J.; Monreal, D.; González, D.; Marín, C.; López-Goñi, I.; Mainar-Jaime, R.C.; Moreno, E.; Blasco, J.M. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet. Res., 2004, 35(1), 1-38.
[http://dx.doi.org/10.1051/vetres:2003037] [PMID: 15099501]
[89]
Taylor, A.W.; Mcdiarmid, A. stability of the avirulent characters of Brucella abortus, strain 19 and strain 45/20 in lactating and pregnant cows. Vet. Rec., 1949.
[90]
Thomas, E.L.; Bracewell, C.D.; Corbel, M.J. Characterisation of Brucella abortus strain 19 cultures isolated from vaccinated cattle. Vet. Rec., 1981, 108(5), 90-93.
[http://dx.doi.org/10.1136/vr.108.5.90] [PMID: 6789543]
[91]
Lalsiamthara, J.; Lee, J.H. Development and trial of vaccines against Brucella. J. Vet. Sci., 2017, 18(S1), 281-290.
[http://dx.doi.org/10.4142/jvs.2017.18.S1.281] [PMID: 28859268]
[92]
Schurig, G.G.; Roop, R.M., II; Bagchi, T.; Boyle, S.; Buhrman, D.; Sriranganathan, N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet. Microbiol., 1991, 28(2), 171-188.
[http://dx.doi.org/10.1016/0378-1135(91)90091-S] [PMID: 1908158]
[93]
Ashford, D.A.; di Pietra, J.; Lingappa, J.; Woods, C.; Noll, H.; Neville, B.; Weyant, R.; Bragg, S.L.; Spiegel, R.A.; Tappero, J.; Perkins, B.A. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine, 2004, 22(25-26), 3435-3439.
[http://dx.doi.org/10.1016/j.vaccine.2004.02.041] [PMID: 15308369]
[94]
Banai, M. Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations. Vet. Microbiol., 2002, 90(1-4), 497-519.
[http://dx.doi.org/10.1016/S0378-1135(02)00231-6] [PMID: 12414167]
[95]
Olsen, S.C.; Stoffregen, W.S. Essential role of vaccines in brucellosis control and eradication programs for livestock. Expert Rev. Vaccines, 2005, 4(6), 915-928.
[http://dx.doi.org/10.1586/14760584.4.6.915] [PMID: 16372886]
[96]
Lord, V.R.; Cherwonogrodzky, J.W.; Schurig, G.G.; Lord, R.D.; Marcano, M.J.; Meléndez, G.E. Venezuelan field trials of vaccines against brucellosis in swine. Am. J. Vet. Res., 1998, 59(5), 546-551.
[PMID: 9582954]
[97]
Xin, X. Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine. Vaccine, 1986, 4(4), 212-216.
[http://dx.doi.org/10.1016/0264-410X(86)90131-3] [PMID: 3541425]
[98]
Perkins, S.D.; Smither, S.J.; Atkins, H.S. Towards a Brucella vaccine for humans. FEMS Microbiol. Rev., 2010, 34(3), 379-394.
[http://dx.doi.org/10.1111/j.1574-6976.2010.00211.x] [PMID: 20180858]
[99]
Pascual, D.W.; Yang, X.; Wang, H.; Goodwin, Z.; Hoffman, C.; Clapp, B. Alternative strategies for vaccination to brucellosis. Microbes Infect., 2017.
[PMID: 29287984]
[100]
Al-Mariri, A.; Tibor, A.; Mertens, P.; De Bolle, X.; Michel, P.; Godefroid, J.; Walravens, K.; Letesson, J.J. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant. Infect. Immun., 2001, 69(8), 4816-4822.
[http://dx.doi.org/10.1128/IAI.69.8.4816-4822.2001] [PMID: 11447155]
[101]
Oliveira, S.C.; Splitter, G.A. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection. Vaccine, 1996, 14(10), 959-962.
[http://dx.doi.org/10.1016/0264-410X(96)00018-7] [PMID: 8873388]
[102]
Yang, X.; Hudson, M.; Walters, N.; Bargatze, R.F.; Pascual, D.W. Selection of protective epitopes for Brucella melitensis by DNA vaccination. Infect. Immun., 2005, 73(11), 7297-7303.
[http://dx.doi.org/10.1128/IAI.73.11.7297-7303.2005] [PMID: 16239526]
[103]
Pasquevich, K.A.; Estein, S.M.; García Samartino, C.; Zwerdling, A.; Coria, L.M.; Barrionuevo, P.; Fossati, C.A.; Giambartolomei, G.H.; Cassataro, J. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect. Immun., 2009, 77(1), 436-445.
[http://dx.doi.org/10.1128/IAI.01151-08] [PMID: 18981242]
[104]
Yang, Y.; Yin, J.; Guo, D.; Lang, X.; Wang, X. Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection. FEMS Immunol. Med. Microbiol., 2011, 61(2), 159-167.
[http://dx.doi.org/10.1111/j.1574-695X.2010.00758.x] [PMID: 21166726]
[105]
den Hartigh, A.B.; Sun, Y.H.; Sondervan, D.; Heuvelmans, N.; Reinders, M.O.; Ficht, T.A.; Tsolis, R.M. Differential requirements for VirB1 and VirB2 during Brucella abortus infection. Infect. Immun., 2004, 72(9), 5143-5149.
[http://dx.doi.org/10.1128/IAI.72.9.5143-5149.2004] [PMID: 15322008]
[106]
Muñoz-Montesino, C.; Andrews, E.; Rivers, R.; González-Smith, A.; Moraga-Cid, G.; Folch, H.; Céspedes, S.; Oñate, A.A. Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells. Infect. Immun., 2004, 72(4), 2081-2087.
[http://dx.doi.org/10.1128/IAI.72.4.2081-2087.2004] [PMID: 15039330]
[107]
Goodwin, Z.I.; Pascual, D.W. Brucellosis vaccines for livestock. Vet. Immunol. Immunopathol., 2016, 181, 51-58.
[http://dx.doi.org/10.1016/j.vetimm.2016.03.011] [PMID: 27032465]

Rights & Permissions Print Cite
Article Metrics
103
8
© 2024 Bentham Science Publishers | Privacy Policy